<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/casNumber>	"641571-10-0" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Trifluoromethyl_compound> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Pyridine> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/alternativeName>	"Tasigna, others" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Novartis_brands> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Receptor_tyrosine_kinase> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Antineoplastic_agent> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#NamedIndividual> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Novartis_brand> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Benzanilides> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Drug:_Ni> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Non-receptor_tyrosine_kinase_inhibitor> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Novartis> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Pyridines> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Orphan_drugs> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/drugbank>	"DB04868" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Orphan_drug> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Benzanilide> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Aminopyrimidine> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/medlinePlus>	"a608002" .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/chEBI>	"52172" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Trifluoromethyl_compounds> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Scleroderma> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/chEMBL>	"255863" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_antineoplastic_agents> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/bioavailability>	"30.0" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Imidazole> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/kegg>	"D08953" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Targeted_therapy> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/pubchem>	"644241" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/2004/02/skos/core#altLabel>	"nilotinib" .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/casNumber>	"(base)" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_antileukemic_drugs> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://caligraph.org/ontology/Antileukemic_drug> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/2002/07/owl#sameAs>	<http://dbpedia.org/resource/Nilotinib> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines_for_Children> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Non-receptor_tyrosine_kinase_inhibitors> .
<http://caligraph.org/resource/Nilotinib>	<http://caligraph.org/ontology/fdaUniiCode>	"F41401512X" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Imidazoles> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Nilotinib" .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Nanjing_Ange_Pharmaceutical> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/List_of_drugs:_Ni> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Category:Aminopyrimidines> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://en.wikipedia.org/wiki/Protein_kinase_inhibitor> .
<http://caligraph.org/resource/Nilotinib>	<http://www.w3.org/2000/01/rdf-schema#label>	"Nilotinib" .